Host-microbiota interactions in genitourinary cancer immunotherapy

2025/07/23 by Xiaofeng Xu, Xiao-Feng Xu, Jin‐Long Cui +10
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Cancer Immunotherapy and Biomarkers #Gut microbiota and health #Tryptophan and brain disorders

paper · doi:10.1016/j.semcancer.2025.07.005

openalex publication_date 2025/07/23 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/02

Citations

• Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
• Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer
• Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium
• Interaction between microbiota and immunity in health and disease
• Pattern recognition receptors in health and diseases
• Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
• The oral microbiota and its role in carcinogenesis
• The gut microbiome: a core regulator of metabolism
• Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
• Periodontitis and risk of cancer: Mechanistic evidence
• Short-chain fatty acids: linking diet, the microbiome and immunity
• Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma